Literature DB >> 34732530

Humoral Response to BNT1622 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease.

Delphine Kervella1, Pierre Braud2, Claire Garandeau3, Celine Phelizot4, Xavier Ambrosi5, Gilles Blancho6, Maryvonne Hourmant7, Lucile Figueres8.   

Abstract

Entities:  

Year:  2021        PMID： 34732530      PMCID： PMC8729483          DOI： 10.2215/CJN.09110721

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  4 in total

1.  The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.

Authors:  Marcia M L Kho; Marlies E J Reinders; Carla C Baan; Debbie van Baarle; Frederike J Bemelman; Dimitri A Diavatopoulos; Ron T Gansevoort; Fiona R M van der Klis; Marion P G Koopmans; A Lianne Messchendorp; Renate G van der Molen; Ester B M Remmerswaal; Nynke Rots; Priya Vart; Rory D de Vries; Luuk B Hilbrands; Jan-Stephan F Sanders
Journal:  Nephrol Dial Transplant       Date:  2021-05-26       Impact factor: 5.992

2.  COVID-19 vaccines and kidney disease.

Authors:  Martin Windpessl; Annette Bruchfeld; Hans-Joachim Anders; Holly Kramer; Meryl Waldman; Laurent Renia; Lisa F P Ng; Zhou Xing; Andreas Kronbichler
Journal:  Nat Rev Nephrol       Date:  2021-02-08       Impact factor: 28.314

3.  Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients.

Authors:  Philippe Attias; Hamza Sakhi; Philippe Rieu; Arvish Soorkia; David Assayag; Sabrina Bouhroum; Patrice Nizard; Khalil El Karoui
Journal:  Kidney Int       Date:  2021-04-20       Impact factor: 10.612
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.